ARTG Entry

SAPHNELO

ARTG entry for SAPHNELO (anifrolumab), ARTG 484545 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: AstraZeneca
• Active ingredient: anifrolumab
• Therapeutic area: Immunology

TGA Public Summary — ARTG 484545